Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.29 USD | +4.15% | +34.89% | +0.27% |
Sales 2024 * | 37.33K 2.99M | Sales 2025 * | 57.5K 4.6M | Capitalization | 223M 17.86B |
---|---|---|---|---|---|
Net income 2024 * | -41M -3.28B | Net income 2025 * | -39M -3.12B | EV / Sales 2024 * | 5,976 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3,880 x |
P/E ratio 2024 * |
-5.14
x | P/E ratio 2025 * |
-5.77
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.06% |
Latest transcript on INmune Bio, Inc.
1 day | +4.15% | ||
1 week | +34.89% | ||
Current month | -3.91% | ||
1 month | -2.92% | ||
3 months | -6.54% | ||
6 months | +62.45% | ||
Current year | +0.27% |
Managers | Title | Age | Since |
---|---|---|---|
David Moss
FOU | Founder | 54 | 31/08/15 |
Mark Lowdell
FOU | Founder | 61 | 31/08/15 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 31/08/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcia Allen
BRD | Director/Board Member | 73 | 18/11/19 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 31/08/15 |
Scott Juda
BRD | Director/Board Member | 53 | 12/03/18 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 11.29 | +4.15% | 77,738 |
25/04/24 | 10.84 | +2.07% | 115,766 |
24/04/24 | 10.62 | +4.73% | 114,535 |
23/04/24 | 10.14 | -4.56% | 178,613 |
22/04/24 | 10.62 | +26.94% | 687,880 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.27% | 212M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- INMB Stock